Sort
326,823 grants matching “clinical trial”
Initiation of a cohort to define pathogenic Mechanisms, Precision diagnosis And Complications of Thrombotic Microangiopathies: The IMPACT Study
$1,580,963Robert A Brodsky · Johns Hopkins University · U54 · FY2025 · HL
Early Check: A Collaborative Innovation to Facilitate Pre-Symptomatic Clinical Trials in Newborns
$1,580,925Donald B Bailey · Research Triangle Institute · U01 · FY2017 · TR
AIM BACK UH3 Transition
$1,580,894Steven Z George · Duke University · UH3 · FY2023 · AT
Anti IL5 and Churg Strauss Syndrome: a double blind, placebo controlled trial
$1,580,856Michael E Wechsler · National Jewish Health · U01 · FY2013 · AI
GENE THERAPY FOR CYSTIC FIBROSIS
$1,580,779University Of North Carolina Chapel Hill · P01 · FY2000 · HL
Biofluid Core
$1,580,507Adam L Boxer · Mayo Clinic Rochester · U19 · FY2025 · AG
SCAN: Standardized Centralized Alzheimer's and Related Dementias Neuroimaging
$1,580,400William J. Jagust · University Of California Berkeley · U24 · FY2025 · AG
IL-13 and Eosinophilic Esophagitis
$1,580,324Marc E. Rothenberg · Cincinnati Childrens Hosp Med Ctr · R01 · FY2009 · DK
RCT Evaluating Improvement Strategies for Addiction Tx
$1,580,323David H Gustafson · University Of Wisconsin-Madison · R01 · FY2008 · DA
National Sleep Research Resource (NSRR)
$1,580,311Susan S Redline · Brigham And Women'S Hospital · R24 · FY2015 · HL
Clinical Trial of Ceftriaxone in ALS
$1,580,123Massachusetts General Hospital · R01 · FY2004 · NS
Cancer and Leukemia Group B
$1,580,095Richard L Schilsky · University Of Chicago · U10 · FY2008 · CA
Cancer Research Consortium of West Michigan (CRCWM)
$1,580,000Kathleen J Yost · Corewell Health · UG1 · FY2016 · CA
Chemoprevention of arsenic-induced skin cancer
$1,579,984Habibul Ahsan · University Of Chicago · R01 · FY2009 · CA
New class of PBP inhibitors to address PBP2-mediated resistance in Neisseria gonorrhoeae
$1,579,751Denis Marc Daigle · Venatorx Pharmaceuticals, Inc. · R01 · FY2022 · AI
Gene Therapy:Translating Basic Science to the Clinic
$1,579,670University Of California San Diego · P01 · FY2001 · HL
1/2: An Anesthesia-Centered Bundle to Reduce Postoperative Pulmonary Complications: The PRIME-AIR Study
$1,579,549Marcos F Vidal Melo · Columbia University Health Sciences · UH3 · FY2022 · HL
ART Modulation of Viral Pathogenesis
$1,579,497Dirk P Dittmer · Univ Of North Carolina Chapel Hill · R01 · FY2025 · DE
High-Resolution, Spinal Cord Stimulation for Non-Opioid Treatment of Neuropathic Pain
$1,579,371Bryan L McLaughlin · Micro-Leads, Inc. · U44 · FY2019 · NS
Selection & Optimization of a Therapeutic Protein for Acute Ischemic Stroke Functional Recovery
$1,579,337Huston Davis Adkisson · Stream Biomedical, Inc. · R44 · FY2020 · NS
Community Ambulation Following Hip Fracture
$1,579,168Jay Steven Magaziner · University Of Maryland Baltimore · R01 · FY2016 · AG
IL-13 and IL-17 dynamics in the asthmatic airway
$1,579,126Dean Sheppard · University Of California, San Francisco · U19 · FY2016 · AI
Statistical and Data Coordinating Center for ALIAS and IMS 111 Trials
$1,579,120Yuko Y Palesch · Medical University Of South Carolina · U01 · FY2009 · NS
Center for Point-of-Care Technologies Research for Sexually Transmitted Diseases
$1,579,040Charlotte Ann Gaydos · Johns Hopkins University · U54 · FY2016 · EB
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$1,578,849Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2019 · DA